Article
Properdin deficiency protects from 5-fluorouracil-induced small intestinal mucositis in a complement activation-independent, interleukin-10-dependent mechanism.
Clinical and experimental immunology - 1 Apr 2017
Jain U, Midgen C A, Woodruff T M, Schwaeble W J, Stover C M, Stadnyk A W
Abstract excerpt
Intestinal mucositis is a serious complication of chemotherapy that leads to significant morbidity that may require dose or drug adjustments. Specific mitigating strategies for mucositis are unavailable, due partly to an incomplete understanding of the pathogenic mechanisms. We have previously shown an effect of properdin, a positive regulator of complement activation, in models of colitis. Here we use...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
